An antimicrobial peptide
Technical Support & Resources

Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.

Visit our FAQ

Contact Us

Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888

Request Technical Support

Technical Support Request

To streamline the process attach the appropriate questionnaire to your inquiry.

Download IHC QuestionnaireDownload WB Questionnaire

View Our Privacy Statement for details on how we use and protect your data. In addition, this site is protected by hCaptcha and its Privacy Policy and Terms of Service apply.

Mastoparan X (trifluoroacetate salt)

Item No. 36903

Technical Information
Formal Name
L-isoleucyl-L-asparaginyl-L-tryptophyl-L-lysylglycyl-L-isoleucyl-L-alanyl-L-alanyl-L-methionyl-L-alanyl-L-lysyl-L-lysyl-L-leucyl-L-leucinamide, trifluoroacetate salt
CAS Number
72093-22-2
Synonyms
  • Mastoparan V
  • MPV
  • MPX
Molecular Formula
C73H126N20O15S • XCF3COOH
Formula Weight
Purity
≥98%
A solid
Peptide Sequence
INWKGIAAMAKKLL-NH2
DMF: 25 mg/mlDMSO: 25 mg/mlEthanol: 50 mg/mlPBS (pH 7.2): 1 mg/ml
λmax
221 nm
SMILES
CC[C@H](C)[C@H](N)C(N[C@@H](CC(N)=O)C(N[C@H](C(N[C@@H](CCCCN)C(NCC(N[C@@H]([C@@H](C)CC)C(N[C@@H](C)C(N[C@@H](C)C(N[C@@H](CCSC)C(N[C@@H](C)C(N[C@@H](CCCCN)C(N[C@@H](CCCCN)C(N[C@@H](CC(C)C)C(N[C@H](C(N)=O)CC(C)C)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)CC1=CNC2=CC=CC=C12)=O)=O.OC(C(F)(F)F)=O
InChi Code
InChI=1S/C73H126N20O15S.C2HF3O2/c1-13-41(7)59(78)72(107)92-56(36-57(77)94)71(106)91-55(35-46-37-80-48-24-16-15-23-47(46)48)70(105)87-49(25-17-20-29-74)65(100)81-38-58(95)93-60(42(8)14-2)73(108)84-43(9)62(97)82-44(10)63(98)86-52(28-32-109-12)66(101)83-45(11)64(99)85-50(26-18-21-30-75)67(102)88-51(27-19-22-31-76)68(103)90-54(34-40(5)6)69(104)89-53(61(79)96)33-39(3)4;3-2(4,5)1(6)7/h15-16,23-24,37,39-45,49-56,59-60,80H,13-14,17-22,25-36,38,74-76,78H2,1-12H3,(H2,77,94)(H2,79,96)(H,81,100)(H,82,97)(H,83,101)(H,84,108)(H,85,99)(H,86,98)(H,87,105)(H,88,102)(H,89,104)(H,90,103)(H,91,106)(H,92,107)(H,93,95);(H,6,7)/t41-,42-,43-,44-,45-,49-,50-,51-,52-,53-,54-,55-,56-,59-,60-;/m0./s1
InChi Key
UOGNJCLOQPJALD-VAYWNKABSA-N
Origin
Synthetic
Shipping & Storage Information
Storage
-20°C
Shipping
Room temperature in continental US; may vary elsewhere
Recommended Products

Certificates of Analysis & Batch Specific Data

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

    Add

    Add

    Add

    Add

    Cayman Chemical
    Visit Our Cancer Resource Center
    Find Tools & Resources to Study the Hallmarks of Cancer
    • Cancer cell signaling & regulation
    • Cancer metabolism
    • Tumor microenvironment
    EXPLORE NOW
    Product Description

    Mastoparan X is an antimicrobial peptide that has been found in wasp venom.1 It is active against several Gram-positive and Gram-negative bacteria (MICs = 3-64 and 4-256 µg/ml, respectively) and induces permeabilization of E. coli cytoplasmic membranes by 86% when used at a concentration of 6.4 µg/ml. Mastoparan X induces GDP/GTP exchange by Gi in a concentration-dependent manner and binds to calmodulin (Kd = ~0.9 nM) in cell-free assays.2,3 It induces necrosis in T98G glioblastoma multiforme (GBM) cells when used at a concentration of 20 µM.4 Mastoparan X (128 µg/ml) induces degranulation of isolated rat peritoneal mast cells and hemolysis of isolated sheep, chicken, and human erythrocytes in a concentration-dependent manner.1 In vivo, mastoparan X (20 mg/kg) increases survival, decreases disease severity, and prevents damage to jejunal villi and crypts in a mouse model of enterohemorrhagic E. coli infection.5

    WARNING This product is not for human or veterinary use.

    References & Product Citations
    Product Description References

    1. Lin, C., -H., Tzen, J.T.C., Shyu, C.-L., et alStructural and biological characterization of mastoparans in the venom of Vespa species in Taiwan. Peptides 32(10), 2027-2036 (2011).

    2. Malencik, D.A., and Anderson, S.R. High affinity binding of the mastoparans by calmodulin. Biochem. Biophys. Res. Commun. 114(1), 50-56 (1983).

    3. Higashijima, T., Burnier, J., and Ross, E.M. Regulation of Gi and Go by mastoparan, related amphiphilic peptides, and hydrophobic amines. Mechanism and structural determinants of activity. The Journal of Biological Chemisty 265(24), 14176-14186 (1990).

    4. da Silva, A.M., Silva-Gonçalves, L.C., Oliveira, F.A., et alPro-necrotic activity of cationic mastoparan peptides in human glioblastoma multiforme cells via membranolytic action. Mol. Neurobiol. 55(7), 5490-5504 (2018).

    5. Zhao, X., Wang, L., Zhi, C., et alThe antimicrobial peptide mastoparan X protects against enterohemorrhagic Escherichia coli O157:H7 infection, inhibits inflammation, and enhances the intestinal epithelial barrier. Front. Microbiol. 12, 644887 (2021).